Purchase any WEBINAR and get
10% Off
CODE: SAVE10
T&C applicable, please referFAQ
Validity : 15th Apr'24 to 25th Apr'24
Sample Quality Control with Molecular Diagnostics
- Universal sample requirements for molecular diagnostics
- Strategies to deal with common challenges
- Challenges unique to PCR assays
- Challenges unique to DNA fluorescent assays
- Challenges unique to NGS assays
- Challenges unique to newer molecular technologies
Overview of the webinar
This webinar explains a variety of issues and how to address them. Common issues such as collection methods, sample inhibition and sample volume will be addressed. Also, each unique technology, from standard PCR, to DNA fluorescent assays, from next generation sequencing to newer technologies such as point of care and digital PCR, will have their various sample challenges addressed. This webinar will give you the tools you need to deal with your laboratories challenges.
Who should attend?
This will benefit a wide array of professionals such as:
- Quality Control
- Assay Development
- Assay Validation
- Research and Development
- Clinical Diagnostics
Why should you attend?
Since the beginning of the PCR revolution in the 1980s, molecular diagnostics have proven to be a useful tool for the clinical laboratory. The ability to analyze a variety of samples for DNA and RNA content have proven to be useful for a large number of clinical conditions using a number of different technologies. However, each technology has its pitfalls with how to handle samples for optimal results. In addition, different technologies have different challenges as to what can inhibit optimal results and each technology has a unique solution to these pitfalls.
Faculty - Mr.Todd Graham
Todd Graham, is a masters-level bench scientist and medical technologist with a host of experience in both the clinical diagnostics and biotechnology fields. Mr. Graham has work for a number of start-up firms in the clinical diagnostics and biotechnology industries, as well as worked for larger firms within both industries. He has a broad level of expertise in assay development for quality control, pharmaceutical development and clinical diagnostics. His particular levels of expertise are molecular diagnostics, PCR, ELISA, quality control and training of bench level personnel in clinical diagnostics and biotechnology. He is also in the process of establishing a consultancy that assists academic labs in transitioning their research to industry by verifying and improving the quality of their work.